The U.S. Food and Drug Administration and the Focused Ultrasound Foundation are co-sponsoring a hybrid public workshop, "Research Roundtable on the Development of Transcranial Ultrasound for Neurological and Psychiatric Applications." Registration for in-person and virtual participation is now open through November 5, 2026.  

Transcranial ultrasound is a rapidly evolving field with promising applications across neuromodulation and blood-brain barrier opening for drug delivery, liquid biopsy, and oncology. This workshop will bring together leading scientific and clinical experts to discuss key considerations related to this technology, including: 

• Scientific knowledge and clinical experience across neuromodulation and BBB opening applications
• Safety considerations and patient risks
• Nonclinical assessments
• Clinical trial design and outcome assessments for therapeutic and diagnostic transcranial ultrasound devices
• Special population needs, including those of pediatric patients
• The evolving transcranial ultrasound landscape and its implications for stakeholders 

Date and Time: November 10, 2026, 9:00 a.m. – 5:00 p.m. ET  

Location: Hilton McLean Tysons Corner, 7920 Jones Branch Drive, McLean, Virginia 22102, and virtually

Registration: This workshop is open to the public. Early registration is encouraged as in-person seating is limited. Register for in-person or virtual participation by November 5, 2026.

For virtual participants, a webcast link will be provided in your registration confirmation email.